Hotline for complaints 1214   
Coronavirus hotline 01/594459   
Hotline for complaints
and the admission of patients to hospitals 01/832700   
Are you a new member? Sign up now
Let us help you
Read about the latest topics.

Guidance and List of Requirements for Registration of Biosimilars Products

Lebanon chose to follow the “GUIDELINES ON EVALUATION OF SIMILAR BIOTHERAPEUTIC PRODUCTS (SBPs)” issued by the WHO, as adopted  by the 60th  meeting of the WHO Expert Committee  on  Biological Standardization,  19-23 October 2009 to evaluate the submitted SBS Files.
© Copyrights reserved to Ministry of Public Health 2020